Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

4.0K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

5.2K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.2K
Abnormal Proliferation02:23

Abnormal Proliferation

4.8K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.8K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

6.1K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.1K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

5.2K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.2K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

7.3K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intraepithelial T cells and tumor-associated macrophages in ovarian cancer patients.

Cancer immunity·2013
Same author

Research on 2D representation method of wireless Micro-Ball endoscopic images.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2013
Same author

Photocatalytic properties of graphdiyne and graphene modified TiOâ‚‚: from theory to experiment.

ACS nano·2013
Same author

Relationship between the structures of flavonoids and oxygen radical absorbance capacity values: a quantum chemical analysis.

The journal of physical chemistry. A·2013
Same author

[Early diagnosis and treatment of acute mesentric ischemia for 42 cases in single center].

Zhonghua wai ke za zhi [Chinese journal of surgery]·2013
Same author

Periodontitis as a novel contributor of adipose tissue inflammation promotes insulin resistance in a rat model.

Journal of periodontology·2013
Same journal

Review of Glypican-3-Targeted Imaging Agents for Hepatocellular Carcinoma.

Cancer biotherapy & radiopharmaceuticals·2026
Same journal

Clinical Laboratory Evaluation of the Biodistribution of a Radiolabeled Antimicrobial Peptide for Precision Radiopharmaceutical-Guided Radionuclide Therapy in Severe Pneumonia Among Immunocompromised Patients with Cancer.

Cancer biotherapy & radiopharmaceuticals·2026
Same journal

Single-Cell Transcriptomics in Triple-Negative Breast Cancer: Implications for Radionuclide Therapy in Precision Oncology.

Cancer biotherapy & radiopharmaceuticals·2026
Same journal

Curved Vertebroplasty System Combined with Targeted Radionuclide Therapy for Tumor-Related Pathological Vertebral Fractures.

Cancer biotherapy & radiopharmaceuticals·2026
Same journal

Development of a Freeze-Dried Bevacizumab Kit for <sup>99m</sup>Tc Radiolabeling and Preclinical Evaluation <i>In Vitro</i> and in Normal Mice.

Cancer biotherapy & radiopharmaceuticals·2026
Same journal

Radionuclide-Based Theranostic Mapping for Spatially Optimized Treatment Planning in Cervical Carcinoma.

Cancer biotherapy & radiopharmaceuticals·2026
See all related articles

Related Experiment Video

Updated: Nov 11, 2025

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

7.8K

circKLHL24 Blocks Breast Cancer Development by Regulating the miR-1204/ALX4 Network.

Guangming Yi1, Dan Wang2, Jianjun Han1

  • 1Department of Oncology, The Third Hospital of Mianyang (Sichuan Mental Health Center), Mianyang City, China.

Cancer Biotherapy & Radiopharmaceuticals
|March 30, 2021
PubMed
Summary
This summary is machine-generated.

Circular RNA circKLHL24 inhibits breast cancer progression by targeting miR-1204 to upregulate ALX4. This mechanism offers a new perspective on breast cancer pathogenesis and potential therapeutic strategies.

Keywords:
ALX4breast cancercircKLHL24miR-1204

More Related Videos

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

1.9K
Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells
16:24

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells

Published on: February 21, 2014

20.5K

Related Experiment Videos

Last Updated: Nov 11, 2025

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

7.8K
Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

1.9K
Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells
16:24

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells

Published on: February 21, 2014

20.5K

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Breast cancer remains a significant threat to women's health globally.
  • Circular RNAs (circRNAs) are emerging as key players in cancer development.
  • The specific role of circKLHL24 in breast cancer is yet to be fully elucidated.

Purpose of the Study:

  • To investigate the functional role of circKLHL24 in breast cancer.
  • To elucidate the molecular mechanism underlying circKLHL24's action in breast cancer.
  • To explore the potential of circKLHL24 as a therapeutic target.

Main Methods:

  • Quantitative real-time PCR for gene expression analysis.
  • Cellular assays (CCK-8, colony formation, Transwell) to assess proliferation and invasion.
  • Glycolysis assays and Western blotting for protein analysis.
  • Dual-luciferase reporter and RNA pull-down assays for interaction validation.
  • In vivo animal studies for tumor growth assessment.

Main Results:

  • circKLHL24 and ALX4 were downregulated, while miR-1204 was upregulated in breast cancer.
  • circKLHL24 overexpression suppressed cell viability, proliferation, migration, invasion, and glycolysis.
  • circKLHL24 acts as a sponge for miR-1204, leading to ALX4 upregulation.
  • Knockdown of ALX4 reversed the effects of miR-1204 deficiency.
  • circKLHL24 inhibited tumor growth in vivo.

Conclusions:

  • circKLHL24 suppresses breast cancer progression by activating ALX4 via sponging miR-1204.
  • This circRNA-miRNA-mRNA axis represents a novel mechanism in breast cancer pathogenesis.
  • circKLHL24 holds potential as a diagnostic biomarker and therapeutic target for breast cancer.